All In Biotech

Drug Trial Radar · NCT03850782

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

515

Actual

Start

Feb 28, 2019

Primary completion

Aug 8, 2025

Study completion Aug 8, 2025

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Feb 22, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.

Conditions

  • Open-Angle Glaucoma
  • Ocular Hypertension

Interventions

  • Bimatoprost (SR)Drug

    Study Eye: Cycles 1 - 3 administrations through the PRN treatment period. Fellow Eye: Standard of care or Bimatoprost SR.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Retreatment or Rescue Administered for Intraocular Pressure (IOP)Time frame: Up to 48 months
  2. Probability of Not Receiving Second Administration or RescueTime frame: Up to 48 months
  3. Number of Patients Experiencing a Treatment Emergent Adverse Event (TEAE)Time frame: Baseline up to 48 months

Locations

108 sites in 16 countries. Site status is shown where the registry gives one.

  • Horizon Eye Specialists & Lasik Centers /ID# 235240

    Sun City, Arizona

  • Atlantis Eye Care /ID# 235530

    Huntington Beach, California

  • Lakeside Vision Center /ID# 234970

    Irvine, California

  • Global Research Foundation /ID# 237350

    Los Angeles, California

  • The Eye Research Foundation /ID# 234521

    Newport Beach, California

  • Byers Eye Institute Stanford /ID# 235544

    Palo Alto, California

  • Foothill Eye Institute /ID# 235640

    Pasadena, California

  • Connecticut Eye Consultants P.C. /ID# 234981

    Danbury, Connecticut

  • Advanced Research, LLC /ID# 236045

    Deerfield Beach, Florida

  • Segal Drug Trials, Inc /ID# 235784

    Delray Beach, Florida

  • International Research Center /ID# 238050

    Tampa, Florida

  • Thomas Eye Group PC /ID# 235737

    Sandy Springs, Georgia

  • Indiana University - Glick Eye Institute /ID# 235886

    Indianapolis, Indiana

  • Retina Partners Midwest, PC /ID# 237876

    Indianapolis, Indiana

  • Tulane University School of Medicine /ID# 237632

    New Orleans, Louisiana

  • Ophthalmic Consultants of Boston /ID# 236534

    Boston, Massachusetts

  • Clinical Eye Research of Boston LLC /ID# 234966

    Winchester, Massachusetts

  • University of Michigan, Kellogg Eye Center /ID# 236496

    Ann Arbor, Michigan

  • Fraser Eye Center /ID# 235790

    Fraser, Michigan

  • Silverstein Eye Centers /ID# 237881

    Kansas City, Missouri

  • Moyes Eye Centers /ID# 234989

    Kansas City, Missouri

  • Alterman Modi & Wolter /ID# 235248

    Poughkeepsie, New York

  • The Ohio State University /ID# 236790

    Columbus, Ohio

  • AMA Eyes Research Institute /ID# 235542

    Marysville, Ohio

  • Dean McGee Eye Institute /ID# 236823

    Oklahoma City, Oklahoma

  • Oklahoma Eye Surgeons /ID# 235849

    Oklahoma City, Oklahoma

  • Drs Fine Hoffman & Sims LLC /ID# 235918

    Eugene, Oregon

  • Ophthalmic Partners, PC /ID# 235741

    Bala-Cynwyd, Pennsylvania

  • Scott and Christie and Associates /ID# 234593

    Cranberry Township, Pennsylvania

  • Black Hills Regional Eye Institute /ID# 235075

    Rapid City, South Dakota

  • Vance Thompson Vision /ID# 235072

    Sioux Falls, South Dakota

  • Eye Specialty Group /ID# 235721

    Memphis, Tennessee

  • Vanderbilt University Medical Center /ID# 237177

    Nashville, Tennessee

  • Advancing Vision Research /ID# 236681

    Smyrna, Tennessee

  • ATX Clinical Trials Inc. dba Keystone Research /ID# 235868

    Austin, Texas

  • Medical Center Ophthalmology Associates - Keystone Research /ID# 235787

    San Antonio, Texas

  • Southern Utah Medical Research /ID# 235602

    St. George, Utah

  • Piedmont Eye Center /ID# 234534

    Lynchburg, Virginia

  • Hospital Italiano /ID# 235851

    Buenos Aires, Argentina

  • Centro Privado de Ojos /ID# 241283

    Ciudad Autonoma Buenos Aires, Argentina

Showing 40 of 108 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.